Judge Allows Case Alleging Violations Of Diet Drugs’ Trademarks To Move Forward
SEATTLE — A Washington federal judge agreed that state law claims filed against medical centers and two physicians who prescribe patients compounded versions of tirzepatide, an FDA-approved drug for diabetes and...To view the full article, register now.
Already a subscriber? Click here to view full article